Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer’s Disease
Yu-on Jeong, Soo Jung Shin, Jun Yong Park, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1800-1800
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 676
New Insights Into the Pathogenesis of Alzheimer's Disease
Liyuan Fan, Chengyuan Mao, Xinchao Hu, et al.
Frontiers in Neurology (2020) Vol. 10
Open Access | Times Cited: 287
Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
Artemis Traikapi, Nikos Konstantinou
Frontiers in Systems Neuroscience (2021) Vol. 15
Open Access | Times Cited: 69
Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer’s Disease
Yaoxue Guo, Junli Zhao, Yizhi Liu, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access | Times Cited: 1
Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer’s disease
Lisa S. Robison, Olivia J. Gannon, Melissa A. Thomas, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 64
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
David A. Loeffler
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 379-411
Open Access | Times Cited: 6
Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer′s disease
Jing Tian, Lan Guo, Shaomei Sui, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 505
Open Access | Times Cited: 54
Ghrelin-Mediated Hippocampal Neurogenesis: Implications for Health and Disease
Luke Buntwal, Martina Sassi, Alwena H. Morgan, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 11, pp. 844-859
Open Access | Times Cited: 45
Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implications
Seong Gak Jeon, Sang Bum Hong, Yunkwon Nam, et al.
Ageing Research Reviews (2019) Vol. 55, pp. 100945-100945
Closed Access | Times Cited: 44
Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model
А. Б. Пупышев, В. М. Беличенко, М. В. Тендитник, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 217, pp. 173406-173406
Closed Access | Times Cited: 25
Antimicrobial Neuropeptides and Their Receptors: Immunoregulator and Therapeutic Targets for Immune Disorders
Kaiqi Chen, Xiaojun Wu, Xiaoke Li, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 568-568
Open Access
Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment
Yuhan Zhang, Ruihua Zhang, Xianwei Wang, et al.
PeerJ (2025) Vol. 13, pp. e18898-e18898
Open Access
Gamma oscillation modulation for cognitive impairment: A systematic review
Emanuela Bartolini, Adolfo Di Crosta, Pasquale La Malva, et al.
Journal of Alzheimer s Disease (2025)
Open Access
The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
Etheresia Pretorius, Janette Bester, Martin Pagé, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 46
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 35
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
Antonio J. López-Gambero, Cristina Rosell‐Valle, Dina Medina‐Vera, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5365-5365
Open Access | Times Cited: 27
Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease
Anna Mengr, Zuzana Šmotková, Andrea Pačesová, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
The Neurocognitive Effects of Ghrelin-induced Signaling on the Hippocampus: A Promising Approach to Alzheimer’s Disease
Robert S Seminara, Charan Jeet, Sharmi Biswas, et al.
Cureus (2018)
Open Access | Times Cited: 36
A new understanding of GHSR1a——independent of ghrelin activation
Xue Xiao, Mingxia Bi, Qian Jiao, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101187-101187
Closed Access | Times Cited: 29
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
Gianfabio Giorgioni, Fabio Del Bello, Wilma Quaglia, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3098-3118
Open Access | Times Cited: 15
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Zhaodi Xia, Ruo‐xin Ma, Jinfeng Wen, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. 4, pp. 1265-1301
Closed Access | Times Cited: 8
Contrasting Metabolic Insufficiency in Aging and Dementia
Dennis A. Turner
Aging and Disease (2021) Vol. 12, Iss. 4, pp. 1081-1081
Open Access | Times Cited: 20
Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: Results from two human laboratory studies
Mehdi Farokhnia, Jeanelle Portelli, Mary R. Lee, et al.
Brain Research (2020) Vol. 1740, pp. 146851-146851
Open Access | Times Cited: 18
Beyond appetite: Acylated ghrelin as a learning, memory and fear behavior-modulating hormone
Niklas Reich, Christian Hölscher
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104952-104952
Open Access | Times Cited: 12
The impact of anorexigenic peptides in experimental models of Alzheimer’s disease pathology
Lenka Maletı́nská, Andrea Popelová, Blanka Železná, et al.
Journal of Endocrinology (2018) Vol. 240, Iss. 2, pp. R47-R72
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top